http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-69345-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_186b9610bfee53b1f19d6d383ac72874
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-42
filingDate 2003-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b46f20b70553a502608153f96edf878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58278e994b1ca5c4324ee7218e9cd78c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bb66083e5a8ae05ac4717c3f7702dd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fabd2d20a39231f1074a6ee604d5c2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b0b0db1bdef7d244baee332471b8b0c
publicationDate 2004-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-69345-A
titleOfInvention Method for treating sensoneural bradyacuasia in patients with diabetes mellitus
abstract The method for treating sensoneural bradyacuasia in the patients with the diabetes mellitus provides for the use of the drugs. In particular, the substances belonging to the group of alpha-lipoic acid are infused intravenously at a dose of 600 mg in 200 ml of the saline solution once a day for 2-3 weeks. Later on, this drug is taken per os at the same dose once a day for two months.
priorityDate 2003-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6112

Total number of triples: 19.